Zika Update

US government contemplates public health funding; World Health Organization advises summer Olympics attendees

Written byTracy Vence
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, IAN BURT“It is very difficult to get people to invest in something that hasn’t happened yet,” National Institute of Allergy and Infectious Diseases Director Anthony Fauci said during a recent US House of Representatives hearing, STAT News reported. Senators this week (May 12) announced a $1.1 billion Zika funding agreement, which is expected to pass in the Senate. The deal is less than the $1.9 billion requested by the Obama administration earlier this year and, as STAT noted, does not cover the restoration of funds intended for Ebola response that have been redirected to Zika preparations. Senator Harry Reid (D-NV) told STAT that the proposed $1.1 billion is “not enough, especially when the amount will likely be reduced further by House Republicans.”

The US Centers for Disease Control and Prevention (CDC) is moving ahead of Congress. The agency today (May 13) invited local health agencies to apply for Zika prep–related grants, following the redirection of $85 million in Department of Health and Human Services (HHS) funds. “These funds will allow states and territories to continue implementation of their Zika preparedness plans, but are not enough to support a comprehensive Zika response and can only temporarily address what is needed,” Stephen Redd, director of CDC’s Office of Public Health Preparedness and Response, said in a statement. The CDC noted that applications are due a month from now, on June 13.

Meanwhile, the World Health Organization (WHO) this week (May 12) advised athletes and others heading to Brazil for ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies